Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stable and Inert Mn(II)-Based and pH-Responsive Contrast Agents.
Botár R, Molnár E, Trencsényi G, Kiss J, Kálmán FK, Tircsó G. Botár R, et al. Among authors: trencsenyi g. J Am Chem Soc. 2020 Jan 29;142(4):1662-1666. doi: 10.1021/jacs.9b09407. Epub 2020 Jan 17. J Am Chem Soc. 2020. PMID: 31927927
Mn(II)-Based MRI Contrast Agent Candidate for Vascular Imaging.
Kálmán FK, Nagy V, Váradi B, Garda Z, Molnár E, Trencsényi G, Kiss J, Même S, Même W, Tóth É, Tircsó G. Kálmán FK, et al. Among authors: trencsenyi g. J Med Chem. 2020 Jun 11;63(11):6057-6065. doi: 10.1021/acs.jmedchem.0c00197. Epub 2020 May 21. J Med Chem. 2020. PMID: 32372648
Synthesis, Physicochemical, Labeling and In Vivo Characterization of 44Sc-Labeled DO3AM-NI as a Hypoxia-Sensitive PET Probe.
Szücs D, Csupász T, Szabó JP, Kis A, Gyuricza B, Arató V, Forgács V, Vágner A, Nagy G, Garai I, Szikra D, Tóth I, Trencsényi G, Tircsó G, Fekete A. Szücs D, et al. Among authors: trencsenyi g. Pharmaceuticals (Basel). 2022 May 26;15(6):666. doi: 10.3390/ph15060666. Pharmaceuticals (Basel). 2022. PMID: 35745585 Free PMC article.
61Cu-Labelled radiodiagnostics of melanoma with NAPamide-targeted radiopharmaceutical.
Kálmán-Szabó I, Bunda S, Lihi N, Szaniszló Z, Szikra D, Szabó Péliné J, Fekete A, Gyuricza B, Szücs D, Papp G, Trencsényi G, Kálmán FK. Kálmán-Szabó I, et al. Among authors: trencsenyi g. Int J Pharm. 2023 Feb 5;632:122527. doi: 10.1016/j.ijpharm.2022.122527. Epub 2022 Dec 23. Int J Pharm. 2023. PMID: 36566825
In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model.
Csikos C, Vágner A, Nagy G, Kálmán-Szabó I, Szabó JP, Ngo MT, Szoboszlai Z, Szikra D, Krasznai ZT, Trencsényi G, Garai I. Csikos C, et al. Among authors: trencsenyi g. Diagnostics (Basel). 2023 Jan 8;13(2):236. doi: 10.3390/diagnostics13020236. Diagnostics (Basel). 2023. PMID: 36673046 Free PMC article.
Cancer cell targeting and imaging with biopolymer-based nanodevices.
Hajdu I, Bodnár M, Trencsényi G, Márián T, Vámosi G, Kollár J, Borbély J. Hajdu I, et al. Among authors: trencsenyi g. Int J Pharm. 2013 Jan 30;441(1-2):234-41. doi: 10.1016/j.ijpharm.2012.11.038. Epub 2012 Dec 14. Int J Pharm. 2013. PMID: 23246780
90 results